MILLENNIUM MANAGEMENT LLC
Position in RARE — Ultragenyx Pharmaceutical Inc.
CIK 1273087
NEW YORK, NY
Position in RARE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,403,946
-$11,723,308 QoQ
Shares Held
760,825
-57.1% QoQ
Ownership
0.772%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#30
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Derivatives in RARE
reported options exposure · as of Jun 30, 2025CallValue
$727,200
CallShares
20,000
PutValue
$563,580
PutShares
15,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. RARE ranks #42 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in RARE
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,403,946 | 760,825 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $37,127,254 | 1,772,184 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,254,812 | 880,644 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,984,327 | 99,213 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $727,200 | 20,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $17,683,358 | 486,341 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $563,580 | 15,500 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $25,795,750 | 712,393 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $29,332,718 | 697,236 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $39,478,773 | 710,689 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $76,065,167 | 1,850,734 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $9,352,007 | 200,300 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $33,052,084 | 707,905 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,365,356 | 28,552 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,883,996 | 108,948 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,557,677 | 55,445 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $691,950 | 15,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $30,550,064 | 761,847 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $35,800,441 | 772,727 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,232,596 | 295,402 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,387,757 | 123,831 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $538,695 | 7,418 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,317,851 | 63,240 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,719,235 | 107,764 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $53,718,950 | 563,387 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,400,900 | 65,000 | Call | Sole | 2021-05-17 | |
| 2020-12-31 | $290,010 | 2,095 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $1,010,539 | 7,300 | Call | Sole | 2021-02-16 | |
| 2020-09-30 | $489,277 | 5,953 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,343,009 | 55,523 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $595,095 | 13,394 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||